Funding for this research was provided by:
APHROZONE
Article History
Received: 5 June 2018
Accepted: 22 August 2018
First Online: 17 September 2018
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of the Korea National Institute for Bioethics Policy following a comprehensive review of study-related procedures (P01-201711-13-002).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.